Profile | GDS5420 / 219674_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 734.12 | 74 |
GSM1296119 | B_lesional_pre-dose | 320.39 | 60 |
GSM1296076 | C_lesional_pre-dose | 323.44 | 62 |
GSM1296092 | D_lesional_pre-dose | 701.8 | 73 |
GSM1296103 | E_lesional_pre-dose | 860.8 | 77 |
GSM1296078 | F_lesional_pre-dose | 413.12 | 66 |
GSM1296107 | G_lesional_pre-dose | 434.98 | 65 |
GSM1296109 | H_lesional_pre-dose | 547.79 | 69 |
GSM1296080 | I_lesional_pre-dose | 800.82 | 75 |
GSM1296090 | J_lesional_pre-dose | 714.88 | 74 |
GSM1296074 | K_lesional_pre-dose | 374.24 | 64 |
GSM1296111 | L_lesional_pre-dose | 336.08 | 61 |
GSM1296099 | M_lesional_pre-dose | 465.69 | 66 |
GSM1296086 | O_lesional_pre-dose | 717.54 | 74 |
GSM1296117 | P_lesional_pre-dose | 350.59 | 61 |
GSM1296113 | Q_lesional_pre-dose | 327.68 | 60 |
GSM1296096 | R_lesional_pre-dose | 603.66 | 71 |
GSM1296105 | S_lesional_pre-dose | 547.66 | 69 |
GSM1296098 | T_lesional_pre-dose | 714.65 | 73 |
GSM1296101 | U_lesional_pre-dose | 826.04 | 76 |
GSM1296121 | V_lesional_pre-dose | 406.6 | 64 |
GSM1296088 | W_lesional_pre-dose | 677.73 | 73 |
GSM1296082 | X_lesional_pre-dose | 717.92 | 74 |
GSM1296115 | Y_lesional_pre-dose | 428.79 | 65 |
GSM1296084 | Z_lesional_pre-dose | 740.07 | 74 |
GSM1296072 | B_lesional_day8 | 383.17 | 63 |
GSM1296069 | L_lesional_day8 | 327.64 | 60 |
GSM1296071 | P_lesional_day8 | 356.04 | 61 |
GSM1296070 | Y_lesional_day8 | 389.63 | 63 |
GSM1296073 | V_lesional_day8 | 341.6 | 62 |
GSM1296034 | A_lesional_day15 | 766.04 | 74 |
GSM1296041 | G_lesional_day15 | 373.93 | 63 |
GSM1296035 | R_lesional_day15 | 652.55 | 72 |
GSM1296038 | U_lesional_day15 | 675.43 | 73 |
GSM1296047 | B_lesional_day15 | 350.67 | 61 |
GSM1296039 | E_lesional_day15 | 423.15 | 65 |
GSM1296042 | H_lesional_day15 | 317.92 | 60 |
GSM1296043 | L_lesional_day15 | 392.72 | 63 |
GSM1296037 | M_lesional_day15 | 712.67 | 74 |
GSM1296046 | P_lesional_day15 | 301.76 | 58 |
GSM1296044 | Q_lesional_day15 | 351.37 | 61 |
GSM1296045 | Y_lesional_day15 | 298.01 | 58 |
GSM1296025 | C_lesional_day15 | 368.18 | 63 |
GSM1296033 | D_lesional_day15 | 683.29 | 73 |
GSM1296027 | I_lesional_day15 | 803.43 | 75 |
GSM1296032 | J_lesional_day15 | 637.64 | 71 |
GSM1296024 | K_lesional_day15 | 496.28 | 68 |
GSM1296031 | W_lesional_day15 | 692.77 | 73 |
GSM1296028 | X_lesional_day15 | 729.22 | 74 |
GSM1296029 | Z_lesional_day15 | 742.65 | 74 |
GSM1296026 | F_lesional_day15 | 577.92 | 70 |
GSM1296030 | O_lesional_day15 | 880.41 | 77 |
GSM1296040 | S_lesional_day15 | 1031.16 | 80 |
GSM1296036 | T_lesional_day15 | 549.61 | 69 |
GSM1296048 | V_lesional_day15 | 431.3 | 65 |
GSM1296059 | A_lesional_day43 | 875.04 | 77 |
GSM1296066 | G_lesional_day43 | 319.85 | 60 |
GSM1296060 | R_lesional_day43 | 473.15 | 67 |
GSM1296063 | U_lesional_day43 | 355.98 | 62 |
GSM1296064 | E_lesional_day43 | 446.8 | 66 |
GSM1296067 | H_lesional_day43 | 459.2 | 65 |
GSM1296062 | M_lesional_day43 | 590.02 | 70 |
GSM1296068 | Q_lesional_day43 | 359.31 | 61 |
GSM1296050 | C_lesional_day43 | 348.67 | 62 |
GSM1296057 | D_lesional_day43 | 688.75 | 73 |
GSM1296052 | I_lesional_day43 | 860.67 | 76 |
GSM1296054 | J_lesional_day43 | 710.95 | 73 |
GSM1296049 | K_lesional_day43 | 427.23 | 65 |
GSM1296055 | W_lesional_day43 | 716.17 | 73 |
GSM1296053 | X_lesional_day43 | 757.54 | 74 |
GSM1296058 | Z_lesional_day43 | 986.4 | 78 |
GSM1296051 | F_lesional_day43 | 496.36 | 68 |
GSM1296056 | O_lesional_day43 | 677.5 | 73 |
GSM1296065 | S_lesional_day43 | 433.79 | 65 |
GSM1296061 | T_lesional_day43 | 611.3 | 70 |
GSM1296095 | A_non-lesional_pre-dose | 646.72 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 283.24 | 57 |
GSM1296077 | C_non-lesional_pre-dose | 303.09 | 60 |
GSM1296093 | D_non-lesional_pre-dose | 841.36 | 76 |
GSM1296104 | E_non-lesional_pre-dose | 499.26 | 68 |
GSM1296079 | F_non-lesional_pre-dose | 398.48 | 64 |
GSM1296108 | G_non-lesional_pre-dose | 435.81 | 65 |
GSM1296110 | H_non-lesional_pre-dose | 348.2 | 60 |
GSM1296081 | I_non-lesional_pre-dose | 946.3 | 78 |
GSM1296091 | J_non-lesional_pre-dose | 692.66 | 73 |
GSM1296075 | K_non-lesional_pre-dose | 321.21 | 61 |
GSM1296112 | L_non-lesional_pre-dose | 341.39 | 60 |
GSM1296100 | M_non-lesional_pre-dose | 741.39 | 74 |
GSM1296087 | O_non-lesional_pre-dose | 910.96 | 77 |
GSM1296118 | P_non-lesional_pre-dose | 287.43 | 57 |
GSM1296114 | Q_non-lesional_pre-dose | 312.73 | 59 |
GSM1296097 | R_non-lesional_pre-dose | 633.64 | 72 |
GSM1296106 | S_non-lesional_pre-dose | 534.78 | 68 |
GSM1296102 | U_non-lesional_pre-dose | 632.46 | 71 |
GSM1296122 | V_non-lesional_pre-dose | 392.88 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 678.86 | 73 |
GSM1296083 | X_non-lesional_pre-dose | 852.73 | 76 |
GSM1296116 | Y_non-lesional_pre-dose | 304.3 | 58 |
GSM1296085 | Z_non-lesional_pre-dose | 926.72 | 78 |